HomeCYTOF • OTCMKTS
add
Altamira Therapeutics Ltd
Previous close
$0.11
Day range
$0.11 - $0.11
Year range
$0.050 - $0.16
Market cap
587.11K USD
Avg Volume
867.00
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (CHF) | 2021info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.34M | 1.10% |
Net income | -17.06M | -108.03% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -5.29M | -0.60% |
Effective tax rate | 1.73% | — |
Balance Sheet
Total assets
Total liabilities
| (CHF) | 2021info | Y/Y change |
|---|---|---|
Cash and short-term investments | 984.19K | -91.26% |
Total assets | 19.17M | -7.83% |
Total liabilities | 6.13M | 52.23% |
Total equity | 13.04M | — |
Shares outstanding | 38.16K | — |
Price to book | 0.00 | — |
Return on assets | -16.70% | — |
Return on capital | -21.60% | — |
Cash Flow
Net change in cash
| (CHF) | 2021info | Y/Y change |
|---|---|---|
Net income | -17.06M | -108.03% |
Cash from operations | -13.67M | -182.29% |
Cash from investing | -3.51M | -51.41% |
Cash from financing | 6.61M | -61.01% |
Net change in cash | -10.27M | -204.06% |
Free cash flow | -7.11M | -59.52% |
About
Founded
2003
Headquarters
Website
Employees
11